Trials / Withdrawn
WithdrawnNCT01939990
Safety Study of Nebivolol for COPD Patients
Nebivolol in Chronic Obstructive Pulmonary Disease
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate the safety and effectiveness of the study drug Nebivolol, in people who suffer with high blood pressure with Chronic Obstructive Pulmonary Disease (COPD).
Detailed description
The study would be a randomized, placebo-controlled trial of 60 hypertensive patients with documented COPD greater than age 40.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | The placebo looks like the study drug but it does not contain active ingredients. |
| DRUG | Nebivolol | 5 to 10mg per day |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2013-09-11
- Last updated
- 2016-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01939990. Inclusion in this directory is not an endorsement.